These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23217418)

  • 1. The global cell therapy industry continues to rise during the second and third quarters of 2012.
    Mason C; McCall MJ; Culme-Seymour EJ; Suthasan S; Edwards-Parton S; Bonfiglio GA; Reeve BC
    Cell Stem Cell; 2012 Dec; 11(6):735-9. PubMed ID: 23217418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O
    BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in the stem cell and regenerative medicine industry.
    Ilic D
    Regen Med; 2012 Sep; 7(5):645-8. PubMed ID: 22954435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative medicine in Europe: global competition and innovation governance.
    Hogarth S; Salter B
    Regen Med; 2010 Nov; 5(6):971-85. PubMed ID: 21082895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug companies cut costs with foreign clinical trials.
    Rai S
    N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry perceptions of barriers to commercialization of regenerative medicine products in the UK.
    Plagnol AC; Rowley E; Martin P; Livesey F
    Regen Med; 2009 Jul; 4(4):549-59. PubMed ID: 19580404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapies.
    Rose JB; Williams DJ
    Regen Med; 2012 May; 7(3):429-38. PubMed ID: 22594333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study agreements and budgets.
    McJilton JS
    Epilepsy Res Suppl; 1993; 10():185-91. PubMed ID: 8251095
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry sponsored bias: NICE may be biased too.
    Toal MJ
    BMJ; 2011 Jan; 342():d474. PubMed ID: 21266434
    [No Abstract]   [Full Text] [Related]  

  • 10. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cell Therapy Catapult: growing a U.K. cell therapy industry generating health and wealth.
    Thompson K; Foster EP
    Stem Cells Dev; 2013 Dec; 22 Suppl 1():35-9. PubMed ID: 24304073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Company stock prices before and after public announcements related to oncology drugs.
    Rothenstein JM; Tomlinson G; Tannock IF; Detsky AS
    J Natl Cancer Inst; 2011 Oct; 103(20):1507-12. PubMed ID: 21949081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Chinese get free drugs in clinical trials.
    Berton E
    Wall St J (East Ed); 2006 Feb; ():B1, B8. PubMed ID: 16528877
    [No Abstract]   [Full Text] [Related]  

  • 14. International Regenerative Medicine Legislative Day.
    Regen Med; 2010 Nov; 5(6):843-4. PubMed ID: 21082883
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients, physicians, and clinical trials: the other side of the coins.
    Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
    J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 19. Physicians and clinical trials. To avoid federal scrutiny, take care when determining fair market value.
    Morillo A
    Mod Healthc; 2013 Sep; 43(38):22. PubMed ID: 24340738
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug reimportation: sitting in the middle.
    DeMaria AN
    J Am Coll Cardiol; 2004 Jan; 43(1):149-50. PubMed ID: 14715197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.